 |
|
|
| |
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Jared M. Baeten1; Thesla Palanee-Phillips2; Elizabeth R. Brown3; Katie Schwartz4; Lydia E. Soto-Torres5; Annalene Nel6; Zeda Rosenberg7; Ian McGowan8; Sharon L. Hillier9; for the MTN-020/ASPIRE Study Team
1Univ of Washington, Seattle, WA, USA; 2Wits Reproductive Hlth and HIV Inst, Johannesburg, South Africa; 3Statistical Cntr for HIV/AIDS Rsr & Prevention, Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA; 4FHI 360, Durham, NC, USA; 5NIAID, NIH, Bethesda, MD, USA; 6Intl Partnership for Microbicides, Paarl, South Africa; 7International Partnership for Microbicides, Silver Spring, MD, USA; 8Univ of Pittsburgh Sch of Med, Pittsburgh, PA, USA; 9Magee-Womens Hosp of the Univ of Pittsburgh Med Cntr, Pittsburgh, PA, USA
WEBCAST link: http://www.croiwebcasts.org/console/player/29584?mediaType=audio&
|
| |
|
|
|
|
|
